<p id="tzpbv"></p>
<pre id="tzpbv"></pre>
<pre id="tzpbv"></pre>
<p id="tzpbv"></p>
<pre id="tzpbv"></pre>
<p id="tzpbv"></p>
<p id="tzpbv"></p>
<p id="tzpbv"><output id="tzpbv"><menuitem id="tzpbv"></menuitem></output></p>
<p id="tzpbv"><output id="tzpbv"></output></p>
<p id="tzpbv"></p>
<pre id="tzpbv"></pre>
<pre id="tzpbv"></pre>
<pre id="tzpbv"><output id="tzpbv"><menuitem id="tzpbv"></menuitem></output></pre>
<p id="tzpbv"></p>
<pre id="tzpbv"><output id="tzpbv"><menuitem id="tzpbv"></menuitem></output></pre>
<p id="tzpbv"><delect id="tzpbv"><menuitem id="tzpbv"></menuitem></delect></p>
<pre id="tzpbv"><output id="tzpbv"><delect id="tzpbv"></delect></output></pre>
<p id="tzpbv"></p>
<pre id="tzpbv"><output id="tzpbv"><listing id="tzpbv"></listing></output></pre>
<pre id="tzpbv"></pre>
<pre id="tzpbv"><p id="tzpbv"></p></pre>
<output id="tzpbv"><output id="tzpbv"></output></output>
<pre id="tzpbv"></pre>
<p id="tzpbv"></p>
中
中文
English
About Us
About Us
Awards
Development Milestones
Our Culture
Social responsibility
Founded in 1995, Hansoh is a leading R&D-driven pharmaceutical company in China.
Founded in 1995, Hansoh is a leading R&D-driven pharmaceutical company in China.
Founded in 1995, Hansoh is a leading R&D-driven pharmaceutical company in China.
Founded in 1995, Hansoh is a leading R&D-driven pharmaceutical company in China.
Founded in 1995, Hansoh is a leading R&D-driven pharmaceutical company in China.
News
Company News
Media Focus
With the objective of 'creating excellence in China's pharmaceuticals and add momentum to "Made in China"',Hansoh endeavors to make its own contribution to the “Healthy China 2030” master plan.
With the objective of 'creating excellence in China's pharmaceuticals and add momentum to "Made in China"',Hansoh endeavors to make its own contribution to the “Healthy China 2030” master plan.
Products
CNS Diseases
Oncology
Anti-infectives
Diabetes
Gastrointestinal
Cardiovascular
Hansoh Pharma has been committed to improving human health through continuous innovation, especially in major disease treatment fields including oncology, CNS, anti-infectives and diabetes.Constantly evolving, Hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
Hansoh Pharma has been committed to improving human health through continuous innovation, especially in major disease treatment fields including oncology, CNS, anti-infectives and diabetes.Constantly evolving, Hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
Hansoh Pharma has been committed to improving human health through continuous innovation, especially in major disease treatment fields including oncology, CNS, anti-infectives and diabetes.Constantly evolving, Hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
Hansoh Pharma has been committed to improving human health through continuous innovation, especially in major disease treatment fields including oncology, CNS, anti-infectives and diabetes.Constantly evolving, Hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
Hansoh Pharma has been committed to improving human health through continuous innovation, especially in major disease treatment fields including oncology, CNS, anti-infectives and diabetes.Constantly evolving, Hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
Hansoh Pharma has been committed to improving human health through continuous innovation, especially in major disease treatment fields including oncology, CNS, anti-infectives and diabetes.Constantly evolving, Hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
R&D
R&D System
R&D Platform
R&D Achievements
National-level R&D Designations
Hansoh has been holding on to the strategy of technology and innovation, and established R&D centers located in Lianyungang and Shanghai.
Hansoh has been holding on to the strategy of technology and innovation, and established R&D centers located in Lianyungang and Shanghai.
Hansoh has been holding on to the strategy of technology and innovation, and established R&D centers located in Lianyungang and Shanghai.
Hansoh has been holding on to the strategy of technology and innovation, and established R&D centers located in Lianyungang and Shanghai.
Services
Marketing Network
Information Inquiry
International Market
Hansoh pursuits the philosophy of “Professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate marketing systems
Hansoh pursuits the philosophy of “Professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate marketing systems
Hansoh pursuits the philosophy of “Professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate
Contact Us
Talent Development
Social Recruitment
Campus Recruitment
Staff Snapshot
Hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
Hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
Hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
Hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
搜索
News
Location：
Home
?
News
?
Company News
Company News
Media Focus
Longest to Date - Median Overall Survival of 30.2 Months! Hansoh Pharma's Ameile? Establishes New Standard for Second-Line Treatment of EGFR-T790M Mutation-Positive NSCLC
The final results of the clinical study (APOLLO st……
2021-09-16
Hansoh Pharma Announces Application for Phase 3 Trial of Ibrexafungerp for the Treatment of Vulvovaginal Candidiasis (VVC)
Shanghai, China — September 13, 2021— Hansoh Pharm……
2021-09-13
Top 3 in China! Hansoh Pharma Ranked Among China's Best Industrial Enterprises in Pharmaceutical R&D Pipeline Again
Recently, the National Pharmaceutical Industry Inf……
2021-08-02
2022
10-28
With Significant Improvement in S&P Global CSA Score, Hansoh Pharma Receives International Recognition for ESG Sustainability
Recently, the S&P Global Corporate Sustainability Assessment (S&P Global CSA) released the latest ESG scores for the first round of participating comp...
Read more
2022
09-16
Hansoh Pharma Ranked Among 2022 Top 100 Chinese Pharmaceutical Innovative Companies and China's Top 5 Pharmaceutical Innovation and Upgrading Role Models
Recently, HealthCare Executive, an authoritative media in the pharmaceutical industry, released the rankings of 2022?Top 100 Chinese Pharmaceutical In...
Read more
2022
09-07
Ranked Among Top 3 in China - Hansoh Pharma’s Brand Value Reaches a New High in 2022
Recently, China Council for Brand Development, China Appraisal Society, National Brand Office of Xinhua News Agency, etc. jointly released the Chinese...
Read more
2022
08-23
Hansoh Pharma Announced Strategic Collaboration with GHDDI on Co-Development of an Oral Anti-Novel Coronavirus Drug
Hansoh Pharmaceutical Group Company Limited (3692.HK, "Hansoh Pharma"), a leading innovation-driven pharmaceutical company in China committed to impro...
Read more
2022
08-16
Provide care in scorching summer to fulfill CSR commitments丨Hansoh Pharma has launched a public welfare program - Care in Summer Days
In recent days, red warnings of high temperatures have been frequently given across China. To help frontline medical staff against high temperatures a...
Read more
2022
01-05
MSCI Upgrades Hansoh Pharma's ESG Rating to A
Recently, MSCI, an international authoritative index company, updated the environmental, social and governance (ESG) rating report for Hansoh Pharma (...
Read more
2021
09-13
Project Cooperation | A Cooperation Between Leto Laboratories and Hansoh Pharma on the Development of a Metabolic Drug
In September 2021, Hansoh Pharmaceutical Group Co., Ltd. (HKEX: 3692) ("Hansoh Pharma") signed a joint project cooperation agreement with Leto Laborat...
Read more
2021
07-28
Thumbs-Up from CDE! Hansoh Pharma's Ameile? Included in Annual Drug Review Report 2020 as a New Good Drug
Recently, the National Medical Products Administration （NMPA） released the Annual Drug Review Report 2020. Ameile? （Almonertinib Mesilate Tablets）, a ...
Read more
1
2
3
4
5
...
14
15
Next page
精品久久久无码人妻字幂
<p id="tzpbv"></p>
<pre id="tzpbv"></pre>
<pre id="tzpbv"></pre>
<p id="tzpbv"></p>
<pre id="tzpbv"></pre>
<p id="tzpbv"></p>
<p id="tzpbv"></p>
<p id="tzpbv"><output id="tzpbv"><menuitem id="tzpbv"></menuitem></output></p>
<p id="tzpbv"><output id="tzpbv"></output></p>
<p id="tzpbv"></p>
<pre id="tzpbv"></pre>
<pre id="tzpbv"></pre>
<pre id="tzpbv"><output id="tzpbv"><menuitem id="tzpbv"></menuitem></output></pre>
<p id="tzpbv"></p>
<pre id="tzpbv"><output id="tzpbv"><menuitem id="tzpbv"></menuitem></output></pre>
<p id="tzpbv"><delect id="tzpbv"><menuitem id="tzpbv"></menuitem></delect></p>
<pre id="tzpbv"><output id="tzpbv"><delect id="tzpbv"></delect></output></pre>
<p id="tzpbv"></p>
<pre id="tzpbv"><output id="tzpbv"><listing id="tzpbv"></listing></output></pre>
<pre id="tzpbv"></pre>
<pre id="tzpbv"><p id="tzpbv"></p></pre>
<output id="tzpbv"><output id="tzpbv"></output></output>
<pre id="tzpbv"></pre>
<p id="tzpbv"></p>
